| ID | 10100 |
| Vaccine Name | TWINRIX |
| Disease Name | Hepatitis A, Hepatitis B |
| Disease Classification | Hepatitic |
| Virus Name | Hepatitis A, Hepatitis B virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Approved |
| Manufacturer | GlaxoSmithKline |
| Year of Manufacturing | NA |
| Manufacturing Country | Rixensart, Belgium |
| Age | 18 years and above |
| Dosage | 3 doses at regimen of 0, 1, and 6 months |
| Administration Route | Intramuscular |
| Adjuvant | Aluminum |
| Target Strain | Strain HM175, HBsAg |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://www.cdc.gov/hepatitis/hav/havfaq.htm#vaccine |
| Additional Links | https://www.fda.gov/vaccines-blood-biologics/vaccines/twinrix
|